USSTOCK.TODAY
Market Closed
Log in Sign up

Adial Pharmaceuticals Inc(ADIL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

Halted
Trading Halted Since 2026-11-05: Trading has been halted. It may resume, and prices shown reflect the last trading day.
ADIL
ADIL
Halted
Adial Pharmaceuticals Inc
At close Oct 28 at 4:00 PM ET (Korea 10/29 05:00)
$5.05
+1.34 ▲ +36.12%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -16.54Insider Own ⓘ 9.2%Shs Outstand ⓘ 2.6MPerf Week ⓘ 22.87%
Market Cap ⓘ 0.01BForward P/E ⓘ -EPS next Y ⓘ 76.54%Insider Trans ⓘ 19.84%Shs Float ⓘ 2.4MPerf Month ⓘ 21.69%
Enterprise Value ⓘ 0.05BPEG ⓘ -EPS next Q ⓘ -0.17Inst Own ⓘ 19.41%Short Float ⓘ 7.54%Perf Quarter ⓘ 53.5%
Income ⓘ -0.06BP/S ⓘ -EPS this Y ⓘ 78.21%Inst Trans ⓘ -11.91%Short Ratio ⓘ 3.19Perf Half Y ⓘ 225.81%
Sales ⓘ 0.00BP/B ⓘ -EPS next 5Y ⓘ 61.9%ROA ⓘ -322.1%Short Interest ⓘ 0.18MPerf YTD ⓘ -8.18%
Book/sh ⓘ -14.61P/C ⓘ 0.46EPS past 3/5Y ⓘ 88.55% 53.46%ROE ⓘ -265.94%52W High ⓘ -46.98% ($9.52)Perf Year ⓘ -46.48%
Cash/sh ⓘ 10.94P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -241.16%52W Low ⓘ 285.5% ($1.31)Perf 3Y ⓘ -90.05%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 45.78%Gross Margin ⓘ -Volatility(W/M) ⓘ 12.87% 12.34%Perf 5Y ⓘ -99.76%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 0.49Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 5.63EPS Q/Q ⓘ -144.05%Profit Margin ⓘ -RSI (14) ⓘ 62.8Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 5.63Sales Q/Q ⓘ -SMA20 ⓘ 31.19% ($3.85)Beta ⓘ 1.65Target Price ⓘ $8.5
Payout ⓘ -Debt/Eq ⓘ -Earnings ⓘ 2026/8/17SMA50 ⓘ 6.36% ($4.75)Rel Volume ⓘ 1.77Prev Close ⓘ $3.71
Employees ⓘ 6LT Debt/Eq ⓘ -EPS/Sales Surpr. ⓘ -989.59% -SMA200 ⓘ 56.02% ($3.24)Avg Volume(3M) ⓘ 0.06MPrice ⓘ $5.05
IPO ⓘ 2018/7/27Option/Short ⓘ No/YesTrades ⓘ 881Volume ⓘ 99,659Change ⓘ 36.12%
Company
ADIL ADILAdial Pharmaceuticals Inc | NASD | Biotechnology Deep dive

🧬 A biotech focused on addiction treatment. AD04 is a therapeutic for alcohol use disorder. Phase 3 trials are set to begin in the second half of 2025, with the FDA approval pathway already in progress.

Quote

Over the past 1 year, roughly in the middle

47% below its 1-year high.

Now $5.05
52w low$1.3152w high$9.52
52W Range46%
Volume ⓘ 99,659

Traded more than usual. That is 177% of its average volume.

B
Overall · fairly good
We judged 6 of the 8 questions below. 2 rate excellent and 2 need caution.
No data for valuation, dividends, or not applicable.
ETFs holding this stock 1 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #481 of 599 in the industry

Based on market cap of $13M.

FAQ

FAQ

What kind of company is ADIL?

ADIL belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of ADIL?

The market cap of ADIL is approximately $13M, ranking 5,347 within its sector.

What is the 52-week high and low for ADIL?

ADIL has recorded a 52-week high of $9.52 and a low of $1.31.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels